Immunomodulatory activity of Terminalia chebula against Salmonella typhimurium in mice by Khan, K.H.
Recent Research in Science and Technology 2009, 1(5): 211–216 
ISSN: 2076-5061 
www.recent-science.com 
 
MEDICAL SCIENCES 
IMMUNOMODULATORY ACTIVITY OF TERMINALIA CHEBULA AGAINST 
SALMONELLA TYPHIMURIUM IN MICE 
 
K. H. Khan1,2 
1Centre for Biotechnology, Faculty of Science, Hamdard University, Jamia Hamdard, New Delhi-110062, India  
2Medical Biotechnology Division, School of Biosciences and Technology, VIT University, Vellore-632014, Tamil Nadu, India 
 
 
Abstract 
Typhoid is a worldwide problem today due to the emergence of multidrug resistance Salmonella typhi and limited scope of vaccine 
against this disease. As the plant product has little side effects and is the source of many compounds having wide range of 
biological activities, diverted the author to study the protective role of Terminalia chebula, against Salmonella typhimurium. The 
author has already reported the protective effect of aqueous extract of the fruits of this plant against S. typhimurium in vitro as well 
as in vivo and also the antioxidant activity against these bacteria. In this study the same extract was evaluated for its 
immunomodulatory activity against S. typhimurium in vivo. Animals pretreated with the same extract at a dose 500 mg/kg body wt 
orally showed an increase in WBC count by 3x103/cu mm and lymphocyte count by 4 % as compared to saline treated control 
challenged with 50000 colony forming unit of S. typhimurium. The drug showed the proliferation of lymphocyte by 102% and 
increase in food pad thickness by 28.87% as compared to infected control in delayed type of hypersensitivity test. Thus the drug 
showed its protective effect through its immunomodulatory activity in mice and can be used in typhoid. 
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Introduction 
Typhoid is endemic in many developing countries 
and remains a substantial public health problem despite 
recent progress in water and sanitation coverage [1]. It is 
an infectious disease caused by Salmonella enterica 
serotype typhi, remains an important worldwide cause of 
morbidity and mortality. It is characterized by high fever, 
rose colored spot, bone marrow depression, diarrhea, 
eosinophilia and various other symptoms reported by us 
in a review article on typhoid [2]. 
 A major impediment to the effective chemotherapy 
of typhoid is the ever increasing numbers of resistant 
strains of S. typhi. More over there is limited efficacy of 
vaccine to the younger population [1,3]. Due to the above 
reasons we diverted our study toward the use of plant 
products as it has less side effects and are the reservoir 
of various organic compounds which act as antimicrobial, 
antioxidant, immunomodulatory and also posses various 
other pharmacological properties required to combat 
infectious diseases. The basic approaches behind the 
management of infectious diseases include either to 
destroy the bacteria, or to booster the immune system of 
an individual by the administration of immunostimulants. 
In humans, S. enterica, serovar Typhimurium (S. 
typhimurium) causes a self-limiting gastroenteritis, while 
in mice it causes a systemic typhoid-like disease, which 
is used as a model of human typhoid [4]. Infection of 
mice with S. typhimurium results in splenomegaly and a 
macrophage mediated immunosuppression. Host 
resistance to systemic salmonellosis is mediated by 
reactive oxygen and nitrogen intermediates, inflammatory 
cytokines, and specific CD4D and CD8D T cells, and B 
cells [5]. 
Medicinal herbs represent a rich source from which 
novel antibacterial chemotherapeutic agents could be 
obtained. A number of plants having high medicinal value 
have been reported by us [6]. Immunomodulatory activity 
of triphala on neutrophil functions was also reported [7]. 
Terminalia chebula Retz is antioxidant, hepatoprotective, 
antimicrobial, adaptogenic and anti-inflammatory as 
reported by this author based on literature survey [3]. The 
aqueous extract of this fruit was reported to have anti 
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Salmonella typhimurium activity in vitro and also in vivo. 
Moreover this author reported that the same extract given 
orally at a dose of 500 mg/kg body wt (T500) showed 
100% protection against 1X105 colony forming units 
(CFU) of S. typhimurium when injected itraperitoneally [8]. 
Further studies were reported by author using the same 
aqueous extract against the oxidative stress induced by 
the same dose of the same bacteria. It was found by 
author that the mice pretreated orally with T500 for a 
period of 30 days followed by challenge with 50000 CFU 
of S. typhimurium showed a reduction of catalase (CAT) 
and lipid peroxidation (LPO) activity and increased in 
reduced glutathione (GSH) activity as compared to saline 
control mice subjected to same dose of bacteria [9].  
In another study the author reported that the same 
dose (T500) for same period of time following the same 
route showed a decrease in xanthine oxidase activity 
(XO), increase in glutathione peroxidase (GPX) and also 
glutathione reductase (GR) activity [3] against same 
doses of  S. typhimurium proving to be antioxidant 
against the same bacteria. The author further studied the 
protective immunological role of the same drugs (T500) 
following oral route against the same doses of bacterium 
and tried to represent his work in this research article. 
 
Material and Methods 
 
Plant material 
 
In this study dried fruits of Terminalia chebula Retz 
were used. The fruits belong to the family Combretaceae. 
It was purchased from the market of Okhla at New Delhi, 
India and was identified by University taxonomist.  
 
Preparation of plant extract  
 
The fruits were washed and dried. Aqueous extract 
of the fruits were used in this experiment. The extract was 
prepared as described by this author [3]. The dried 
powder of the extract was stored in sterile tube at 4 

C. 
The sterile powder was named as T in this manuscript.  
 
Microorganisms 
 
During this study wild type of S. typhimurium was 
used. The standard strain of S. typhimurium was obtained 
from National Salmonella Phage Typing Centre, Lady 
Harding Medical College, New Delhi, India. This bacterial 
strain was further characterized and authenticated by the 
Department of Microbiology, Majeedia Hospital, New 
Delhi, India. 
Animals 
Swiss albino mice were used as an animal model. 
Mice weighing about 20-25 gm were used in this study. 
These animals were supplied by Central Animal House, 
Hamdard University, New Delhi-62 and kept under 
standard laboratory condition for 12 hr light dark cycle at 
25 10 oC.  The above animals were supplied with pellet 
diet (Lipton, India) and water ad labitum.  Much 
precaution and care was taken so to provide 
approximately no pain to animals. 
Research was performed according to the 
internationally accepted principles for laboratory animal 
use. All the studies were conducted at Jamia Hamdard, 
Hamdard University, New Delhi according to ethical 
guidelines of the Jamia Hamdard Animal Ethics 
Committee and "The Committee for the Purpose of 
Control and Supervision of Experiments on Animals" 
(CPCSEA) in the use of animals for scientific research. 
 
Dose and Dosages 
The drug used in this experiment was aqueous 
extract of T. chebula (T) by oral route. Animals pretreated 
with T500 for a period of 30 days provide 100% 
protection against 1X105 CFU of S. typhimurium as 
reported by this author earlier [8]. In determining the 
enzymes of oxidative stress the author used 50000 CFU 
of S. typhimurium intraperitoneally [3] [9]. As this work is 
the extension of previous work the author used T500 
orally and 50000 CFU of S. typhimurium intraperitoneally. 
The animals were divided into following groups containing 
six animals in each group. 
The study comprised of following treatment schedule. 
Group S: Normal saline. 
Group S+B: Normal saline+50000 CFU of S. 
typhimurium (wild). 
Group T500: Aqueous extract of T. chebula (500 
mg/kg body wt). 
GroupT500+B: Aqueous extract of T. chebula (500 
mg/kg body wt) + 50000 CFU of S. typhimurium (wild). 
 
Counting of white blood corpuscles 
The mice were divided into three groups having six 
mice in each group. First and second group was 
pretreated orally with saline for a period of 30 days and 
third group was pretreated with T500 for same period of 
time and through same route. After 30 days of 
pretreatment the animals in second and third group were 
injected with 50000 CFU of S. typhimurium 
intraperitoneally. At 7th day of post infection (PI) the blood 
of animals were collected and the leukocytes were 
counted at Majeedia Hospital, New Delhi-62, India. 
 
Counting of lymphocytes 
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In this study the blood was used from the same 
animals. The blood was collected in dried tube and 
lymphocyte counts were taken at Majeedia Hospital, New 
Delhi-62 for authentic results.  
 
Lymphocyte proliferation assay 
Eighteen animals were used for this experiment. The 
animals were divided into three groups having six 
animals in each group. The animals of first and second 
groups were treated with saline orally for a period of 30 
days and the third group with T500 for same period of 
time through the same route. After pretreatment for a 
period of 30 days the animals of the second as well as 
third groups were challenged with 50000 CFU of S. 
typhimurium. Blood was then withdrawn from retro-orbital 
plexus of mice. Lymphocytes were then separated from 
the blood by density gradient centrifugation on 
Histopaque-1077. The buffy coats were used to isolate 
mononuclear cells. Sterile pasteur pipette were used to 
pipette out mononuclear cells from buffy coat. The cells 
were pellet out at 400Xg for 10 minutes. Cells in the 
pellet was then suspended carefully in 1 ml of growth 
medium (RPMI-1640) containing 10% FBS and 
recommended concentration of antibiotic. The viability of 
cells was assessed by the trypan blue exclusion method. 
The cells were then plated in 96-well culture plates 
(Tarsons) at a cell density of 1X106 cells/well. ConA was 
used as a mitogenic agent. The culture plate was 
incubated at 37 

C in CO2 (5%) incubator (Forma 
Scientific,Ohio), with water-saturated air for 6 days. After 
6 days the cells were pulsed with 1 Ci of [3H]-
methylthymidine. After 18 hr of radiaoactive pulse, cells 
were harvested and the amount of [3H]-thymidine 
incorporated into DNA was determined by liquid 
scintillation spectroscopy [10]. 
 
Delayed-type hypersensitivity 
Delayed type hypersensitivity (DTH) is a type IV 
hypersensitivity mediated by sensitive TH helper cells 
which release various cytokines. It is one of the 
manifestations of cell mediated immunity. For the 
determination of DTH the requirement is the preparation 
of antigen from the organism, immunization of animals 
with the same organism and then finding out the DTH of 
the drug against the test organism in the terms of foot 
pad swelling. 
 
Preparation of antigen from S. typhimurium by 
sonication 
The sonicated antigen was made as described by 
Tiwari and Kamat [11]. Briefly, S. typhimurium were 
grown at 37°C on nutrient agar, suspended in phosphate 
buffer saline (PBS), pH 7.2, harvested and washed with 
PBS. The suspended cells were disrupted by sonication, 
and centrifuged at 10,000 rpm for 1 hr. The supernatant 
was lyophilized and the protein contents of the lyophilized 
material were estimated by Lowry’s method [12]. 
 
Immunization of animals 
The experiment of DTH was carried out by standard 
footpad swelling method as enumerated by Collins and 
Mackaness [13]. The animals were divided into two 
groups having six animals in each group. One group was 
pretreated with saline and other with T500. These groups 
were immunized with 50000 CFU of S. typhimurium 
intraperitoneally. 
 
Analyzing the effect of drugs on DTH response 
against S. typhimurium 
On the 7th day of immunization, the right hind 
footpad was injected with S. typhimurium cell lysate. The 
left hind foot was injected with saline and served as 
control. The food pad swellings were then recorded at an 
interval of 3hr, 6hr, 12hr, 24hr, 48hr and 72hr. Results 
have been summarized in Fig 4. 
      
Results 
Forty six grams of drug was obtained from 100 
grams of dried fruit as reported by this author earlier [3]. 
This lyophilized aqueous extract was used in this 
experiment. 
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Fig. 1. Total WBC induced by S. typhimurium in mice when 
pretreated  for 30 days.  
S = Mice pretreated with saline for a period of 30 days. S+B = 
Saline treated mice (S) + 50000 CFU of S. typhimurium. T500+B = 
Mice pretreated with 500 mg/kg body wt of T for 30 days followed 
by challenge with 50000 CFU of S. ryphimurium. Values are 
significantly different. ***P< 0.001.     
 
Swiss albino mice pretreated with saline for a period 
of 30 days orally and then subjected to 50000 CFU of S. 
typhimurium by intraperitoneal route showed a decrease 
of total leucocyte count by 5x103 /cu mm at day 7th of PI 
as compared to normal uninfected saline treated control.  
Mice pretreated with T500 for a period of 30 days 
followed by challenge with same doses of S. typhimurium 
exhibits an increase in total leucocytes count by 3x103/cu 
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mm as compared to infected saline treated control 
subjected to same doses of S. typhimurium (50000 CFU) 
(Fig1). 
Animals pretreated with saline for a period of 30 
days followed by challenge with 50000 CFU of S. 
typhimurium showed a decrease of lymphocyte count by 
6% at day 7th of PI as compared to saline control mice 
not subjected to the S.typhimurium. Mice pretreated with 
T500 through oral route for a period of 30 days followed 
by challenge with 50000 CFU of S. typhimurium 
intraperitoneally showed an increase of lymphocyte count 
by 4% as compared the the control mice subjected to 
same doses of S. typhimurium through the same route at 
day 7th of PI (Fig 2). 
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Fig. 2. Percent lymphocyte count induced by S. typhimurium in 
mice    pretreated for a period of 30 days.  
S = Mice pretreated with saline for a period of 30 days, S+B = 
Saline pretreated mice (S) challenged with 50000 CFU of S. 
typhimurium. T500+B =Mice pretreated with 500 mg/kg body wt of 
T for 30 days followed by challenge with 50000 CFU of S. 
typhimurium. Values are significantly different. ***P< 0.001. 
 
Swiss albino mice pretreated with T500 through oral 
route subjected to 50000 CFU of S. typhimurium 
intraperitoneally showed an increase of 102% in the level 
of T cell proliferation in lymphocyte proliferation assay as 
compared to saline treated control subjected to same 
doses of bacteria through same route (Fig 3). 
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Fig. 3. Lymphocyte proliferation induced by S typhimurium in mice 
pretreated  for a period of 30 days.  
S = Mice treated with saline,  S’ = Saline (S) + ConA (5ug), 
SB = Saline pretreated animal + (50000 CFU of S. typhimuriium), 
SB’= Saline (S) +Bacteria (50000 CFU of S. typhimurium) + ConA 
(5ug),  T500+B= Mice pretreated with 500mg/kg body wt of T + 
50000 CFU of S. typhimurium, T500+B’ = Mice pretreated with 
500mg/kg body wt of T + 50000 CFU of S. typhimurium + ConA 
(5ug). 
Values are significantly different. ***P< 0.001. 
  The drug T500 when evaluated for its DTH activity 
against S. typhimurium showed an increase of 28.87% of 
footpad thickness as compared to the saline treated control 
subjected to same doses of S. typhimurium (Fig 4).   
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Fig. 4. DTH response induced by water extract of Terminalia chebula 
against S. typhimurium. Terminalia chebula was administered at a 
dose of 500mg/kg body wt. and compared with saline treated 
control. Foot pad thickness is the difference of thickness of treated 
and control foot pad. Values are significantly different. ***P< 0.001.     
 
Discussion 
Encounters with bacterial pathogens lead to subclini- 
cal infection, most of the time, with mounting of active 
humoral and cell-mediated immune responses culminat- 
ing in the elimination of the organism [14]. Blood contains 
leukocytes or white blood cells that play an important role 
to defense the body against microorganism. The 
category of leukocyte includes lymphocytes, granulocytes, 
monocytes and macrophages. Lymphocytes are 
mononuclear leukocytes that mediate humoral and cell 
mediated immunity. The lymphocytes are of three types 
namely B lymphocytes, T lymphocytes and null cells. B 
cells bring about humoral immunity. T cells are again 
divided into T helper cells (TH cells), T suppressor cells 
(Ts cells), T cytotoxic cells (Tc cells) or T killer cells (Tk 
cells) and T delayed type hypersensitivity cells (TD cells). 
The activated TH cells secrete lymphokines. The 
lymphokines increase the response of B cells, T killer 
cells and T suppressor cells. The B cells are activated to 
produce antibody. TD cell is also known as TH1 cells that 
secrete variety of cytokines that recruit and activate 
macrophages and other nonspecific inflammatory cells. 
Activated macrphages exhibit increased level of 
phagocytosis and an increased ability to kill 
microorganism through various cytotoxic mediators. The 
influx and activation of macrophages in the DTH 
response is important in host defense against parasites 
and bacteria that live within the cells, where circulating 
antibody cannot reach them [15]. 
Earlier it was reported by this author that T500 
showed 100% protection against 1X105 C.F.U of S. 
typhimurium when injected itraperitoneally [8].  In this 
study animals pretreated with T500 followed by challenge 
with 50000 CFU of S. typhimurium showed an increase in 
the level of WBC or leucocyte explained the encounter of 
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bacteria against the cells of the immune system 
indicating protection of the body against S. typhimurium. 
Further study showed the increase in lymphocyte counts 
which again claimed the protective effect of drugs against 
S. typhimurium. This was again confirmed by studying 
the lymphocyte proliferation assay which clearly indicated 
the proliferation of T-Lymphocyte and finally the 
protective effect of drugs. 
The drug (T500) caused an increase in footpad 
thickness in mice at 48hr followed by a decrease of 
swelling at 72hr as compared to saline treated control, 
which indicates that the plants extract exhibited DTH 
response against S. typhimurium. As CMI plays major 
role in defense against salmonella infection, the induction 
of DTH response by drug treatment may be 
the mechanism of protection against salmonellosis. 
Aqueous extract of T. chebula was reported to 
produce an increase in humoral antibody (HA) titer and 
delayed-type hypersensitivity (DTH) in mice [16] which 
further supports this study. As there is an increase in 
lymphocytes in animals pretreated with T500 followed by 
challenge with 50000 CFU of S. typhimurium it can also 
be concluded that the killing of the S. typhimurium takes 
place via humoral immune response also. Over all it 
proves that the protection to animals against S. 
typhimurium is due to the immunomodulatory activity of 
the drug. 
ROS propagate inflammation by stimulating release 
of cytokines, such as interleukin-1, tumour necrosis 
factor-, and interferon-, which stimulate recruitment of 
additional neutrophils and macrophages. Thus, free 
radicals are important mediators that provoke or sustain 
inflammatory processes and, consequently, their 
neutralisation by antioxidants and radical scavengers 
which can attenuate inflammation [17]. 
T. chebula contains a number of compounds like 
chebulagic acid [18], gallic acid [19], ellagic acid [20] 
which are highly antioxidant. The above said plant was 
also reported to have an antioxidant property [21]-[23]. 
The immunomodulatory activity of this extract may be 
due to its antioxidant activity. 
 
Conclusion 
The fruits of Indian medicinal plant T. chebula are 
known for their pharmacological activity and in this 
manuscript it has been shown that the extract can be 
used as an effective immunomodulator against S. 
typhimurium. Aqueous extract of T. chebula showed an 
increase in WBC and lyphocytes count against S. 
typhimurium. The extract also proliferated lymphocyte 
and exhibited delayed type of hypersensitivity. The result 
showed its immunomodulatory activities. Further study is 
required to test this drug on other immunological 
parameters to confirm its immunological activities against 
S. typhimurium. 
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